Variant report
Variant | nsv482125 |
---|---|
Chromosome Location | chr1:152126071-152131704 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:10)
- CpG islands (count:183)
- Chromatin interactive region (count:9)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:10 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ATF2 | chr1:152128831-152129266 | GM12878 | blood: | n/a | n/a |
2 | CTCF | chr1:152131520-152131670 | RPTEC | kidney: | n/a | n/a |
3 | CTCF | chr1:152128092-152128203 | Lung_OC | lung: | n/a | n/a |
4 | CTCF | chr1:152130780-152130930 | HBMEC | blood vessel: | n/a | chr1:152130786-152130804 |
5 | CTCF | chr1:152127857-152127925 | LNCaP | prostate: | n/a | n/a |
6 | CTCF | chr1:152129240-152129390 | HMF | breast: | n/a | n/a |
7 | MAX | chr1:152129300-152129305 | NB4 | blood: | n/a | n/a |
8 | POLR2A | chr1:152129151-152129206 | A549 | lung: | n/a | n/a |
9 | ZBTB33 | chr1:152128335-152128791 | GM12878 | blood: | n/a | n/a |
10 | ZBTB33 | chr1:152127792-152128334 | GM12878 | blood: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr1:152126975-152127025 | BJ | skin: | n/a |
2 | chr1:152128681-152128731 | ECC-1 | luminal epithelium: | n/a |
3 | chr1:152128681-152128731 | SK-N-SH_RA | brain: | n/a |
4 | chr1:152128681-152128731 | HCF | heart: | n/a |
5 | chr1:152128681-152128731 | ovcar-3 | ovarian: | n/a |
6 | chr1:152130772-152130822 | HRPEpiC | eye: | n/a |
7 | chr1:152126975-152127025 | RPTEC | kidney: | n/a |
8 | chr1:152130772-152130822 | LNCaP | prostate: | n/a |
9 | chr1:152130772-152130822 | NT2-D1 | testis: | n/a |
10 | chr1:152128681-152128731 | NHDF-neo | bronchial: | n/a |
11 | chr1:152130772-152130822 | HUVEC | blood vessel: | n/a |
12 | chr1:152130772-152130822 | U87 | brain: | n/a |
13 | chr1:152126975-152127025 | HCT-116 | colon: | n/a |
14 | chr1:152126975-152127025 | AG09319 | gingival: | n/a |
15 | chr1:152128681-152128731 | LNCaP | prostate: | n/a |
16 | chr1:152126975-152127025 | GM06990 | blood: | n/a |
17 | chr1:152126975-152127025 | HepG2 | liver: | n/a |
18 | chr1:152130772-152130822 | ECC-1 | luminal epithelium: | n/a |
19 | chr1:152126975-152127025 | U87 | brain: | n/a |
20 | chr1:152126975-152127025 | GM12891 | blood: | n/a |
21 | chr1:152128681-152128731 | SAEC | small airway: | n/a |
22 | chr1:152130772-152130822 | MCF-7 | breast: | n/a |
23 | chr1:152126975-152127025 | AG04449 | skin: | fetal |
24 | chr1:152128681-152128731 | HCPEpiC | choroid plexus: | n/a |
25 | chr1:152130772-152130822 | AG09309 | skin: | n/a |
26 | chr1:152130772-152130822 | HL-60 | blood: | n/a |
27 | chr1:152126975-152127025 | PANC-1 | pancreas: | n/a |
28 | chr1:152126975-152127025 | NT2-D1 | testis: | n/a |
29 | chr1:152128681-152128731 | AoSMC | blood vessel: | n/a |
30 | chr1:152126975-152127025 | SKMC | muscle: | n/a |
31 | chr1:152128681-152128731 | HEK293 | kidney: | embryo |
32 | chr1:152126975-152127025 | HCPEpiC | choroid plexus: | n/a |
33 | chr1:152126975-152127025 | Hela-S3 | cervix: | n/a |
34 | chr1:152128681-152128731 | GM12892 | blood: | n/a |
35 | chr1:152130772-152130822 | AoSMC | blood vessel: | n/a |
36 | chr1:152126975-152127025 | PrEC | prostate: | n/a |
37 | chr1:152128681-152128731 | AG04449 | skin: | fetal |
38 | chr1:152128681-152128731 | MCF10A-Er-Src | breast: | n/a |
39 | chr1:152128681-152128731 | HRPEpiC | eye: | n/a |
40 | chr1:152130772-152130822 | HEEpiC | esophagus: | n/a |
41 | chr1:152128681-152128731 | BJ | skin: | n/a |
42 | chr1:152130772-152130822 | Hepatocyte | liver: | n/a |
43 | chr1:152130772-152130822 | PrEC | prostate: | n/a |
44 | chr1:152126975-152127025 | HL-60 | blood: | n/a |
45 | chr1:152126975-152127025 | GM19239 | blood: | n/a |
46 | chr1:152126975-152127025 | PFSK-1 | brain: | n/a |
47 | chr1:152128681-152128731 | SKMC | muscle: | n/a |
48 | chr1:152130772-152130822 | Caco-2 | colon: | n/a |
49 | chr1:152126975-152127025 | NH-A | brain: | n/a |
50 | chr1:152130772-152130822 | HCT-116 | colon: | n/a |
(count:9 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr1:151999004..152000652-chr1:152126763..152128781,2 | MCF-7 | breast: | |
2 | chr1:152125491..152127414-chr1:152134352..152136756,3 | MCF-7 | breast: | |
3 | chr1:152008096..152009641-chr1:152128962..152130538,2 | MCF-7 | breast: | |
4 | chr1:152125198..152127725-chr1:152135136..152137599,3 | MCF-7 | breast: | |
5 | chr1:152124388..152127212-chr1:152139209..152141234,3 | MCF-7 | breast: | |
6 | chr1:152008008..152010475-chr1:152123735..152126708,2 | MCF-7 | breast: | |
7 | chr1:152126007..152128051-chr1:152155968..152157757,2 | MCF-7 | breast: | |
8 | chr1:152128532..152130259-chr1:152138292..152140629,2 | MCF-7 | breast: | |
9 | chr1:152020176..152022085-chr1:152129939..152131843,2 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
RPTN | TF binding region |
RPTN | CpG island |
ENSG00000163191 | chromatin interactions |
ENSG00000237975 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs71625157 | chr1:152126130-152126131 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
2 | rs183145618 | chr1:152126194-152126195 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
3 | rs367932876 | chr1:152126209-152126210 | Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
4 | rs184998513 | chr1:152126219-152126220 | Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
5 | rs566569043 | chr1:152126236-152126237 | Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
6 | rs535564571 | chr1:152126250-152126251 | Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
7 | rs76099250 | chr1:152126279-152126280 | Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
8 | rs555860144 | chr1:152126324-152126325 | Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
9 | rs370747085 | chr1:152126351-152126352 | Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
10 | rs189902321 | chr1:152126377-152126378 | Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
11 | rs544364042 | chr1:152126378-152126379 | Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
12 | rs557983919 | chr1:152126421-152126422 | Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
13 | rs577994942 | chr1:152126457-152126458 | Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
14 | rs3001978 | chr1:152126467-152126468 | Enhancers | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
15 | rs183205329 | chr1:152126479-152126480 | Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
16 | rs115971123 | chr1:152126576-152126577 | Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
17 | rs149879144 | chr1:152126594-152126595 | Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
18 | rs111718070 | chr1:152126605-152126606 | Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
19 | rs144891635 | chr1:152126631-152126632 | Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
20 | rs187804703 | chr1:152126638-152126639 | Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
21 | rs571695404 | chr1:152126683-152126684 | Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
22 | rs531315865 | chr1:152126687-152126688 | Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
23 | rs532546840 | chr1:152126719-152126720 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs113033594 | chr1:152126739-152126740 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs550716237 | chr1:152126879-152126880 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs570758739 | chr1:152126904-152126905 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs201046127 | chr1:152126934-152126935 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs562753399 | chr1:152126936-152126937 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs191401461 | chr1:152126937-152126938 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs546925285 | chr1:152126984-152126985 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs566509159 | chr1:152126987-152126988 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs536688982 | chr1:152127008-152127009 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs535814874 | chr1:152127117-152127118 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs183764806 | chr1:152127208-152127209 | Weak transcription Enhancers Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs188506223 | chr1:152127222-152127223 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
36 | rs199661540 | chr1:152127237-152127238 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
37 | rs201916415 | chr1:152127241-152127242 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
38 | rs201541838 | chr1:152127255-152127256 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
39 | rs200762358 | chr1:152127259-152127260 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
40 | rs192865821 | chr1:152127264-152127265 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
41 | rs201203302 | chr1:152127272-152127273 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
42 | rs554078916 | chr1:152127273-152127274 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
43 | rs201797962 | chr1:152127282-152127283 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
44 | rs202164910 | chr1:152127292-152127293 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
45 | rs369541690 | chr1:152127301-152127302 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
46 | rs542568199 | chr1:152127306-152127307 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
47 | rs372825443 | chr1:152127308-152127309 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
48 | rs377081641 | chr1:152127347-152127348 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
49 | rs184952075 | chr1:152127348-152127349 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
50 | rs200983551 | chr1:152127351-152127352 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 21129771 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Autosomal dominant nocturnal frontal lobe epilepsy | 18472482 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Thrombocytopenia-absent radius syndrome | 21933853 | CNVD |
Psychiatric disorder | 22848183 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Liposarcoma | 21253554 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Melanoma | 18172304 | CNVD |
Breast cancer | 20409316 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17393978 | CNVD |
Cervical cancer | 21062161 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Cancer | 21183584 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Lung cancer | 18438408 | CNVD |
Rett syndrome | 21593744 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Systemic lupus erythematosus | 21956041 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17133270 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Cervical cancer | 21063398 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 20632083 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 21264507 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Cancer | 16751803 | CNVD |
Prostate cancer | 16705090 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16461572 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Breast cancer | 17899364 | CNVD |
Bladder cancer | 19088036 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Breast cancer | 21858162 | CNVD |
Breast cancer | 21611746 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 16608533 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Osteosarcoma | 17242211 | CNVD |
Ovarian cancer | 17242211 | CNVD |
Ovine squamous-cell carcinoma | 17599052 | CNVD |
Schizophrenia | 18990708 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Plasma-cell dyscrasia | 16705089 | CNVD |
Myeloma | 17024118 | CNVD |
Cancer | 17060936 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Type 2 diabetes | 19141583 | CNVD |
Chordoma | 18071362 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17001317 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Follicular lymphoma | 18703704 | CNVD |
Breast cancer | 21509527 | CNVD |
Bladder cancer | 21909424 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Trisomy 5 syndrome | 21098271 | CNVD |
Ependymoma | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Gastrointestinal cancer | 16790693 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:152121200-152126200 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
2 | chr1:152125600-152127400 | Enhancers | Primary T regulatory cells fromperipheralblood | blood |
3 | chr1:152126200-152126800 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
4 | chr1:152126600-152127400 | Enhancers | Primary T helper 17 cells PMA-I stimulated | -- |
5 | chr1:152126800-152127000 | Enhancers | Primary T helper cells PMA-I stimulated | -- |
6 | chr1:152126800-152134400 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
7 | chr1:152127000-152127400 | Enhancers | Primary T helper memory cells from peripheral blood 2 | blood |
8 | chr1:152127200-152129200 | Active TSS | Brain Substantia Nigra | brain |
9 | chr1:152129800-152133200 | Weak transcription | GM12878-XiMat | blood |
10 | chr1:152131200-152131600 | Enhancers | Stomach Mucosa | stomach |
11 | chr1:152131200-152131800 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
12 | chr1:152131200-152132000 | Enhancers | Primary hematopoietic stem cells | blood |
13 | chr1:152131200-152132400 | Enhancers | NHDF-Ad | bronchial |
14 | chr1:152131200-152132600 | Enhancers | Monocytes-CD14+_RO01746 | blood |
15 | chr1:152131200-152135200 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
16 | chr1:152131400-152131800 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
17 | chr1:152131400-152132000 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
18 | chr1:152131400-152132200 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
19 | chr1:152131400-152133800 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
20 | chr1:152131400-152145800 | Enhancers | Primary monocytes fromperipheralblood | blood |
21 | chr1:152131600-152132200 | Enhancers | Osteobl | bone |
22 | chr1:152131600-152137000 | Weak transcription | Stomach Mucosa | stomach |